Anti-inflammatory cytokines content in different clinical uveitis course complicated by the optic nerve inflammation
DOI:
https://doi.org/10.31288/oftalmolzh201612426Keywords:
uveitis, complicated by the inflammation of the optic nerve, interleukin-4, interleukin-10Abstract
The purpose of this work was to study the content of anti-inflammatory cytokines interleukin-4 (IL-4) and interleukin-10 (IL-10) in different clinical uveitis course complicated by the optic nerve inflammation.
Material and Methods. 132 patients with uveitis complicated by the optic nerve inflammation in the active stage were examined and treated. Anti-inflammatory cytokines (IL-4, IL-10) were determined in the blood serum of all the patients by immunoenzyme method.
Results. It was found that the content of interleukin-4 in uveitis complicated by the inflammation of the optic nerve was 2.3 times and interleukin-10 - 2.6 times lower in comparison with control group, respectively (p <0.05). We found that the lower concentration of interleukin-10 in the blood serum correlates with the recurrent uveitis complicated by the inflammation of the optic nerve, as evidenced by the revealed strong inverse correlation (r = -0,7327; p <0,05).
Conclusions. It was found, that in the active phase of uveitis complicated by the inflammation of the optic nerve, there was a significant reduction in the content of anti-inflammatory cytokines in the blood compared with the control group: interleukin-4 and interleukin-10. Lower concentration of IL-10 in the blood serum correlates with recurrent disease course.
References
1. Drozdova EA, Tarasova LN, Teplova SN, Alekhina TV. [Immunological characteristics of uveitis in case of systemic diseases]. Vestnik oftalmologii. 2004;120(4):24-26. Russian.
2. Katargina LA, Khvatova AV. [Endogenous uveitis in children and adolescents]. Meditsina. 2000:320. Russian.
3. Lacomba MC, Martin CM, Chamond RR et al. Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch. Ophthalmol. 2000;118:768-772.https://doi.org/10.1001/archopht.118.6.768
4. Tian L, Lei B, Shao J. et al. AAV2-mediated combined subretinal delivery of IFN-?and IL-4 reduces the severity of experimental autoimmune uveoretinitis. PLoS. One. 2012;7(6):e37995.https://doi.org/10.1371/journal.pone.0037995
5. Cordero-Coma M, Calleja S. Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses. Ocul. Immunol. Inflamm. 2013;21,(3):212-219.https://doi.org/10.3109/09273948.2013.770888
6. Chen W., Zhao B., Jiang R et al. Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis. Curr. Mol. Med. 2015;15:511-518.https://doi.org/10.2174/1566524015666150731100012
7. Li Q., Sun B., Matteson DM et al. Cytokines and apoptotic molecules in experimental melanin-protein induced uveitis (EMIU) and experimental autoimmune uveoretinitis (EAU). Autoimmunity. 1999;30:171-182.https://doi.org/10.3109/08916939908993851
8. Takase H., Futagami Y., Yoshida T. et al. Cytokine Profile in Aqueous Humor and Sera of Patients with Infectious or Noninfectious Uveitis. Invest. Ophthalmol. Vis. Sci. 2006:47(4):1557-1561.
9. Rupesh V., Somasheila M., Virender I. Current approach in diagnosis and management of anterior uveitis. Indian. J. Ophthalmol. 2010;58(1):11-19.https://doi.org/10.4103/0301-4738.58468
10. Foster C. Uveitis: A Guide for Teachers and Parents. The Ocular Immunology and Uveitis Foundation. Cambridge, USA. 2004:5-89.
11. Kaufmann U., Diedrichs-M?hring M., Wildner G. Dynamics of intraocular IFN-?, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis. PLoS. One. 2012;7(11):e49008.https://doi.org/10.1371/journal.pone.0049008
12. Pleyer U, Mondino B. Uveitis and immunological disorders (Essentials in Ophthalmology). Pleyer U.New York. 2005:126-127.
13. De Groot-Mijnes J., Rothova A., Van Loon A. et al. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. Am. J. Ophthalmol. 2006;141:313-318.https://doi.org/10.1016/j.ajo.2005.09.017
14. Gratacos J, Collado A., Filella X. et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Rheumatol BrJ. 1994;33:927-931.https://doi.org/10.1093/rheumatology/33.10.927
15. Damico FM, Cunha-Neto E, Goldberg AC. et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest. Ophthalmol. Vis. Sci. 2005;46:2465-2471.https://doi.org/10.1167/iovs.04-1273
16. Smet M., Taylor S, Bodaghi B. et al. Understanding uveitis: The impact of research on visual outcomes. Prog. Retin. Eye. Res. 2011;30:452-470.https://doi.org/10.1016/j.preteyeres.2011.06.005
17. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Immunol. 1997;178:69-78.https://doi.org/10.1006/cimm.1997.1121
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Н. В. Панченко, М. Н. Самофалова, М. В. Фрянцева
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
